Search Results - "LOPEZ DE ARGUMEDO, G"

Utility Of 18F-Fluorodeoxyglucose Positron Emission Tomography (PET/CT) in the Staging and Treatment Plan Evaluation of Head and Neck Squamous Cell Carcinoma by Cacicedo, J, Del Hoyo, O, Rodeño, E, Fernandez, I, Rodriguez, O, Dolado, A, Martinez-Indart, L, Municio, J, Gomez, J, Sancho, A, Lopez de Argumedo, G, Alvarez, J, Gaafar, A, Espinosa, J, Bilbao, P

Get full text

Phase II clinical trial of cisplatin, 5-fluorouracil, and ifosfamide as treatment for advanced locoregional head and neck carcinoma by SANCHEZ PARRA, M, CHURRUCA, C, PAREDES, A, LACASTA, A, LOPEZ DE ARGUMEDO, G, ALVAREZ, I, ABAD, T, EGANA, L, GUIMON, E, PIERA, J. M

“…The association of ifosfamide with cisplatin and 5-fluorouracil for the management of advanced squamous cell carcinoma of the head and neck was assessed in…”
Get full text

Induction cisplatin, paclitaxel, and 5FU (PTF) before definitive local therapy for locally advanced esophageal squamous cell carcinoma (SCC) by Fernandez, R., Lopez de Argumedo, G., Fuente, N., Ferreiro, J., Martinez, M., Azkona, E., Gutierrez, E., Iza, E., Casas, R., Mane, J.

“…Abstract only 115 Background: Induction chemotherapy for locally advanced oesophageal SCC is controversial. Triple combination is under study with promising…”
Get full text

Treatment of locally advanced esophageal carcinoma with induction cisplatin-paclitaxel-5FU (PTF) before local therapy by Fernandez-Rodriguez, R., Ancizar, N., Lopez de Argumedo, G., Ruiz de Lobera, A., Lopez Vivanco, G., Gil Negrete, A., Sancho, A., Carrera, S., Munoz, A., Mane, J. M.

“…Abstract only 15174 Background: We analyse induction therapy with PTF before local definitive therapy in terms of response, resectability, toxicity and…”
Get full text

6067 First line treatment with FOLFIRI-Bevacizumab for advanced colorectal cancer (ACRC): a single institution experience with 127 consecutive unselected patients by de Lobera Martinez, A. Ruiz, Ciordia, I. Marrodan, Uribelarrea, E. Azkona, Gutierrez, A. Sancho, Llarena, A. Muñoz, Bueno, A. Martinez, de Argumedo Esnarrizaga, G. Lopez, Fernandez, N. Fuente, Cornejo, R. Casas, Vivanco, G. Lopez

Get full text

Concomitant radiotherapy (RT) with docetaxel for unresectable locally advanced non-small cell lung cancer (LA-NSCLC) by Fuente, N., Mañé, J. M., Rubio, I., Carrera, S., Martínez-Bueno, A., de Argumedo, G. López, Ferreiro, J., Abón, G., Garrido, P., López-Vivanco, G.

“…Abstract only…”
Get full text

Folfiri-bevacizumab as first line treatment for advanced colorectal cancer (ACRC): Results from 77 consecutive unsellected patients by de Lobera, A. Ruiz, Mañé, J. M., López-Vivanco, G., Muñoz, A., de Argumedo, G. López, Ferreiro, J., de Corcuera, I. Diaz, Fuente, N., Moreno, A., Rubio, I.

“…Abstract only…”
Get full text

Toxicity of bevacizumab (BV) in metastatic colorectal carcinoma (MCRC): Analysis in 173 consecutive patients by Ferreiro, J., de Corcuera, I. Diaz, Mañé, J. M., Sancho, A., Muñoz, A., Fuente, N., de Argumedo, G. López, Moreno, A., Rubio, I., de Lobera, A. Ruiz

“…Abstract only…”
Get full text